Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Gastroenterología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
A Randomized, Open-label, Cross-over Study Comparing the Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD): The Advantage Study
INTERVENTIONAL
Inicio: 1 de sept de 2015
ID: NCT02551224
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b Multicenter, Randomized, Placebo- Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Moderately to Severely Active Ulcerative Colitis
INTERVENTIONAL
Inicio: 9 de oct de 2023
ID: NCT06049017
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Multi-center, Parallel Group, Double Blind, Placebo and Formoterol Controlled 14 Day Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Patients With COPD
INTERVENTIONAL
Inicio: 1 de oct de 2007
ID: NCT00557466
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, 5 Treatment Arms, 4-period, Incomplete Cross-over Study to Determine the Effect of 6 Weeks Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (FDC) (2.5 / 5 µg; and 5 / 5 µg) (Delivered by the Respimat® Inhaler) Compared With Tiotropium (5 µg), Olodaterol (5 µg ) and Placebo (Delivered by the Respimat® Inhaler) on Lung Hyperinflation and Exercise Endurance Time During Constant Work Rate Cycle Ergometry in Patients With Chronic Obstructive Pulmonary Disease (COPD) [MORACTO TM 1]
INTERVENTIONAL
Inicio: 1 de mar de 2012
ID: NCT01533922
Reclutando
Fase 3
ClinicalTrials.gov
A Randomized, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Paltusotine in Adults With Carcinoid Syndrome Due to Well-Differentiated Neuroendocrine Tumors
INTERVENTIONAL
Inicio: 19 de nov de 2025
ID: NCT07087054
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of DEB025/Alisporivir in Combination With Peg-IFNα2a and Ribavirin in Hepatitis C Genotype 1 Treatment-naïve Patients
INTERVENTIONAL
Inicio: 1 de mar de 2011
ID: NCT01318694
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Double-Dummy, Multicenter, Active-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab IV Compared to Adalimumab SC in Subjects With Ulcerative Colitis
INTERVENTIONAL
Inicio: 29 de jun de 2015
ID: NCT02497469
Reclutando
Fase 3
ClinicalTrials.gov
An Open-label Randomized Trial of the Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy Alone for Advanced HER2-positive Biliary Tract Cancer
INTERVENTIONAL
Inicio: 19 de jul de 2024
ID: NCT06282575
Reclutando
ClinicalTrials.gov
Effect of Consumption of a Dairy Product Designed for Pregnant and Lactating Women on the Composition of Human Milk. A Quasi-experimental Study in a Vulnerable Population
INTERVENTIONAL
Inicio: 1 de ago de 2025
ID: NCT07173881
Aún no recluta
Fase 2
ClinicalTrials.gov
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Development Program to Evaluate the Efficacy and Safety of LY4268989 (MORF-057) for the Treatment of Adults With Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
INTERVENTIONAL
Inicio: 1 de abr de 2026
ID: NCT07415044
Completado
ClinicalTrials.gov
Interstage Assessment of Remnant Liver Function in ALPPS: Can SPECT Hepatobiliary Scintigraphy Provide Any Additional Value in Predicting Risk of Posthepatectomy Liver Failure?
OBSERVATIONAL
Inicio: 1 de jul de 2011
ID: NCT02846441
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
INTERVENTIONAL
Inicio: 1 de jul de 2012
ID: NCT01634152
Completado
ClinicalTrials.gov
Bacterial Infections in Patients with Cirrhosis in Argentina
OBSERVATIONAL
Inicio: 16 de oct de 2018
ID: NCT03919032
Completado
ClinicalTrials.gov
Usefulness of Wireless pH Monitoring in the Diagnosis of Gastroesophageal Reflux Disease
OBSERVATIONAL
Inicio: 20 de jun de 2021
ID: NCT05452603
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects With Nonalcoholic Steatohepatitis and Fibrosis
INTERVENTIONAL
Inicio: 18 de ago de 2021
ID: NCT05011305
Reclutando
ClinicalTrials.gov
Proof-of-Concept Case-Control Study for Hepatocellular Carcinoma Identification Using Delta-HLD Technology (HIDE)
OBSERVATIONAL
Inicio: 18 de may de 2023
ID: NCT07148310
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Open-Label, Multicenter Phase 3 Trial of Domvanalimab, Zimberelimab, and Chemotherapy Versus Nivolumab and Chemotherapy in Participants With Previously Untreated Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma
INTERVENTIONAL
Inicio: 21 de nov de 2022
ID: NCT05568095
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Randomized, Parallel Group Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects With Carcinoid Syndrome
INTERVENTIONAL
Inicio: 22 de abr de 2022
ID: NCT05361668
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 ug and 5 ug Once Daily) Compared to Placebo Over 12 Weeks in Mild Persistent Asthma
INTERVENTIONAL
Inicio: 1 de mar de 2011
ID: NCT01316380
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Nonalcoholic Steatohepatitis (NASH) and Fibrosis
INTERVENTIONAL
Inicio: 1 de mar de 2016
ID: NCT02704403
Anterior
1
...
19
20
21
...
434
Siguiente
Filtros